Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 3 de 3
Filtrar
Mais filtros

Base de dados
Tipo de documento
Intervalo de ano de publicação
1.
Parasit Vectors ; 14(1): 474, 2021 Sep 15.
Artigo em Inglês | MEDLINE | ID: mdl-34526120

RESUMO

Lymphatic filariasis (LF) is a parasitic disease caused by the worms Wuchereria bancrofti, Brugia malayi, or Brugia timori. It is a tropical and subtropical illness that affects approximately 67 million people worldwide and that still requires better diagnostic tools to prevent its spread and enhance the effectiveness of control procedures. Traditional parasitological tests and diagnostic methods based on whole protein extracts from different worms are known for problems related to sample time collection, sensitivity, and specificity. More recently, new diagnostic tools based on immunological methods using recombinant antigens have been developed. The current review describes the several recombinant antigens used as tools for lymphatic filariasis diagnosis in antigen and antibody capture assays, highlighting their advantages and limitations as well as the main commercial tests developed based on them. The literature chronology is from 1991 to 2021. First, it describes the historical background related to the identification of relevant antigens and the generation of the recombinant polypeptides used for the LF diagnosis, also detailing features specific to each antigen. The subsequent section then discusses the use of those proteins to develop antigen and antibody capture tests to detect LF. So far, studies focusing on antibody capture assays are based on 13 different antigens with at least six commercially available tests, with five proteins further used for the development of antigen capture tests. Five antigens explored in this paper belong to the SXP/RAL-2 family (BmSXP, Bm14, WbSXP-1, Wb14, WbL), and the others are BmShp-1, Bm33, BmR1, BmVAH, WbVAH, BmALT-1, BmALT-2, and Wb123. It is expected that advances in research with these antigens will allow further development of tests combining both sensitivity and specificity with low costs, assisting the Global Program to Eliminate Lymphatic Filariasis (GPELF).


Assuntos
Anticorpos Anti-Helmínticos/sangue , Antígenos de Helmintos/genética , Antígenos de Helmintos/imunologia , Filariose Linfática/diagnóstico , Filariose Linfática/parasitologia , Animais , Anticorpos Anti-Helmínticos/imunologia , Antígenos de Helmintos/classificação , Brugia/química , Brugia/imunologia , Filariose Linfática/classificação , Proteínas de Helminto/genética , Proteínas de Helminto/imunologia , Humanos , Imunoglobulina G/imunologia , Sensibilidade e Especificidade , Wuchereria bancrofti/química , Wuchereria bancrofti/imunologia
2.
Gene ; 224(1-2): 35-44, 1998 Dec 11.
Artigo em Inglês | MEDLINE | ID: mdl-9931421

RESUMO

The BCL7A gene, which maps to human chromosome 12q24.13, was cloned through its direct involvement with MYC and IGH in a three-way translocation in a Burkitt lymphoma cell line. Here, we describe the identification of two related human genes, BCL7B and BCL7C, which share 90% identity to the amino-terminal 51 amino acids of human BCL7A, as well as 41% identity in the same region to Drosophila melanogaster, Caenorhabditis elegans, and Brugia malayi EST sequences. This degree of relatedness in the amino-terminal domain suggests we have defined a new gene family of unknown function. There was little sequence conservation between the family members outside this conserved domain and no identified protein motifs could be deduced. Human BCL7B and BCL7C mapped to chromosome 7q11.23, and 16p11, respectively. No chromosomal rearrangements affecting BCL7B or BCL7C were detected in lymphoid malignancies. BCL7B did, however, map within the region of 7q11.23 which is commonly deleted in the congenital disorder, Williams syndrome.


Assuntos
Sondas de DNA/genética , Proteínas de Neoplasias , Proteínas , Síndrome de Williams/genética , Sequência de Aminoácidos , Animais , Proteínas Reguladoras de Apoptose , Sequência de Bases , Brugia/química , Brugia/genética , Mapeamento Cromossômico , Cromossomos Humanos Par 16/genética , Cromossomos Humanos Par 7/genética , Drosophila melanogaster/química , Drosophila melanogaster/genética , Expressão Gênica , Genes/genética , Humanos , Hibridização in Situ Fluorescente , Proteínas dos Microfilamentos/genética , Dados de Sequência Molecular , Família Multigênica/genética , RNA Mensageiro/genética , RNA Mensageiro/metabolismo , Alinhamento de Sequência , Deleção de Sequência , Homologia de Sequência de Aminoácidos , Distribuição Tecidual
3.
Parasitol Res ; 78(3): 252-6, 1992.
Artigo em Inglês | MEDLINE | ID: mdl-1350345

RESUMO

Immunocytochemical techniques were used to detect FMRFamide-like immunoreactivity in adults of the filarial nematodes Dirofilaria immitis and Brugia pahangi. An FMRFamide-like peptide was also located in third- and fourth-stage larvae of D. immitis. Positive immunoreactivity was observed in all parasites examined, irrespective of developmental stage. The major areas of positive immunoreactivity were located in the anterior nerve ring, lateral/dorso-ventral nerves, cephalic papillary ganglia and lateral ganglia. No staining was seen in the intestine or gonads of any parasite. These results indicate that filarial worms possess a peptidergic component in their nervous system. The possible role of an FMRFamide-like peptide in the control of certain physiological events is discussed.


Assuntos
Brugia/química , Dirofilaria immitis/química , Hormônios de Invertebrado/análise , Neuropeptídeos/análise , Neurotransmissores/análise , Animais , FMRFamida , Imunofluorescência , Técnicas Imunoenzimáticas , Imuno-Histoquímica , Larva/química
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA